ARTELO BIOSCIENCES, INC. (ARTL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US04301G7060
ARTELO BIOSCIENCES, INC. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -11.40 m USD |
| EBIT | -12.69 m USD |
| Net income | -12.88 m USD |
| Diluted EPS – continuing operations | -12.52 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ARTELO BIOSCIENCES, INC.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
More stocks
- SusGlobal Energy Corp. (SNRG)
- CANNAPHARMARX, INC. (CPMD)
- WASTE ENERGY CORP. (WAST)
- FUSE GROUP HOLDING INC. (FUST)
- Artisan Consumer Goods, Inc. (ARRT)
- ESCALON MEDICAL CORP (ESMC)
- CONECTISYS CORP (CONC)
- Aphoenity International Holdings Inc. (LDSN)
- CIMG Inc. (CIMG)
- Leader Capital Holdings Corp. (LCHD)
- HNO International, Inc. (HNOI)
- Agentix Corp. (AGTX)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.